OREX

Orexigen Therapeutics, Inc. News Headlines

$5.68
*  
0.05
0.87%
Get OREX Alerts
*Delayed - data as of Aug. 29, 2014 15:53 ET  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Vivus Acquires Patent Rights To Qsymia Ingredient
8/25/2014 1:38:00 PM - Seeking Alpha

Belviq Sales Rise 2%
8/25/2014 9:57:00 AM - Seeking Alpha

Belviq Sales Flatten Out But Edge Above Qsymia
8/15/2014 4:10:00 PM - Seeking Alpha

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain
8/8/2014 1:28:00 PM - Seeking Alpha

Vivus Beats The Street - Still Has A Loss
8/8/2014 10:04:00 AM - Seeking Alpha

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com

Orexigen Hits Expectations But That Is Not The Big News
8/7/2014 1:25:00 PM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha

One-Time Stock Sale Boosts Arena To Profit
8/4/2014 11:34:00 AM - Seeking Alpha

Possible Delay In Orexigen Approval Process In Europe
7/31/2014 9:54:00 AM - Seeking Alpha

Arena Conference Call Sets Stage For Near Term Equity Movement
7/28/2014 2:07:00 PM - Seeking Alpha

Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/16/2014 8:00:00 AM - Zacks.com

Arena Stock Holds On Expected Dip In Sales - Bottom May Be In
7/11/2014 1:01:00 PM - Seeking Alpha

Close Calls: Heluva Week
6/20/2014 5:11:00 PM - Market Intelligence Center

The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha

Orexigen Therapeutics To Present At Wells Fargo Conference; Webcast At 1:50 PM
6/18/2014 12:50:00 PM - RTT News

Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
6/18/2014 10:33:00 AM - Zacks.com

Orexigen (OREX) in Focus: Stock Moves 7.5% Higher - Tale of the Tape
6/17/2014 9:46:00 AM - Zacks.com

What Will It Take For Arena Stock To Rise?
6/16/2014 4:19:00 PM - Seeking Alpha

Vivus Suit Preserves Exclusivity Of Qsymia - For Now
6/13/2014 2:56:00 PM - Seeking Alpha

Arena's Belviq Sales Do More Than Recover
6/13/2014 2:49:00 PM - Seeking Alpha

Orexigen Slumps as Obesity Drug Approval Delayed - Analyst Blog
6/12/2014 6:28:00 PM - Zacks.com

Orexigen Therapeutics (OREX) in Focus: Stock Tumbles 14.7% - Tale of the Tape
6/12/2014 8:56:00 AM - Zacks.com

Cramer's Lightning Round - Trains Are On The Rails (6/11/14)
6/12/2014 4:47:00 AM - Seeking Alpha

Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%
6/11/2014 3:48:14 PM - Benzinga